Scholar Rock Holding (SRRK) Return on Capital Employed (2018 - 2026)

Scholar Rock Holding's (SRRK) quarterly Return on Capital Employed came in at 99.87% in Q1 2026, down 3280.0% year-on-year from 3.14% in Q1 2025, and up 8.46% quarter-over-quarter from 109.1% in Q4 2025.

Scholar Rock Holding (SRRK) Return on Capital Employed (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 99.87% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 3280.0% year-over-year to 99.87% in Q1 2026; TTM through Mar 2026 was 99.87%, a 3280.0% decrease from a year earlier, with the FY2025 full-year figure at 100.12%, down 2728.0% from the prior year.
  • Return on Capital Employed grew to 99.87% in Q1 2026 per SRRK's latest filing, from 109.1% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 34.62% in Q3 2022 and bottomed at 141.01% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 69.04% (2023), against an average of 76.71%.
  • Across the five-year window, Return on Capital Employed sank 7311 bps in 2024 and soared 2566 bps in 2025, its largest moves.
  • Year by year, Return on Capital Employed stood at 39.77% in 2022, then tumbled by 74 bps to 69.04% in 2023, then sank by 30 bps to 89.99% in 2024, then retreated by 21 bps to 109.1% in 2025, then gained by 8 bps to 99.87% in 2026.
  • Per Business Quant, the three latest SRRK Return on Capital Employed figures stand at 99.87% (Q1 2026), 109.1% (Q4 2025), and 115.35% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -31.80%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.46%
4 NuCana 279.75 Bn 279.75 Bn - -68.47%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 10.19%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -68.84%
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -99.87%

Historic Data

Download Data
DateValue
Mar 31, 2026 -99.87%
Dec 31, 2025 -109.10%
Sep 30, 2025 -115.35%
Jun 30, 2025 -99.99%
Mar 31, 2025 -67.07%
Dec 31, 2024 -89.99%
Sep 30, 2024 -141.01%
Jun 30, 2024 -97.91%
Mar 31, 2024 -75.18%
Dec 31, 2023 -69.04%
Sep 30, 2023 -67.90%
Jun 30, 2023 -59.48%
Mar 31, 2023 -54.13%
Dec 31, 2022 -39.77%
Sep 30, 2022 -34.62%
Jun 30, 2022 -40.19%
Mar 31, 2022 -43.54%
Dec 31, 2021 -54.79%
Sep 30, 2021 -48.15%
Jun 30, 2021 -38.38%